Innovative Eyewear Inc. (LUCY) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Innovative Eyewear Inc. stock (LUCY) is currently trading at $1.09. Innovative Eyewear Inc. PS ratio (Price-to-Sales) is 2.46. Analyst consensus price target for LUCY is $3.00. WallStSmart rates LUCY as Sell.
- LUCY PE ratio analysis and historical PE chart
- LUCY PS ratio (Price-to-Sales) history and trend
- LUCY intrinsic value — DCF, Graham Number, EPV models
- LUCY stock price prediction 2025 2026 2027 2028 2029 2030
- LUCY fair value vs current price
- LUCY insider transactions and insider buying
- Is LUCY undervalued or overvalued?
- Innovative Eyewear Inc. financial analysis — revenue, earnings, cash flow
- LUCY Piotroski F-Score and Altman Z-Score
- LUCY analyst price target and Smart Rating
Innovative Eyewear Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Innovative Eyewear Inc. (LUCY) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, revenue growth. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Innovative Eyewear Inc. (LUCY) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
Revenue surging 163.50% year-over-year
Supporting Valuation Data
Innovative Eyewear Inc. (LUCY) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Very low institutional interest at 7.32%
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 2.46x sales
Innovative Eyewear Inc. (LUCY) Detailed Analysis Report
Overall Assessment
This company scores 34/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 2 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Revenue Growth. Valuation metrics including Price/Book (0.56) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 163.50%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Institutional Own.. Some valuation metrics including Price/Sales (2.46) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -74.10%, Operating Margin at -287.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -74.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 163.50% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
LUCY Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
LUCY's Price-to-Sales ratio of 2.46x trades at a deep discount to its historical average of 9.64x (12th percentile). The current valuation is 94% below its historical high of 41.32x set in Sep 2024, and 118% above its historical low of 1.13x in Apr 2024. Over the past 12 months, the PS ratio has compressed from ~9.0x as trailing revenue scaled faster than the stock price.
Compare LUCY with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Innovative Eyewear Inc. (LUCY) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Innovative Eyewear Inc. is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 2M with 164% growth year-over-year.
Key Findings
Revenue growing at 164% YoY, reaching 2M. This pace significantly outperforms most MEDICAL INSTRUMENTS & SUPPLIES peers.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Innovative Eyewear Inc. maintain 164%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 3.23, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Innovative Eyewear Inc..
Bottom Line
Innovative Eyewear Inc. is a high-conviction growth story with revenue accelerating at 164% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Innovative Eyewear Inc.(LUCY)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Innovative Eyewear Inc. (LUCY) is at the forefront of the smart eyewear market, combining cutting-edge technology with contemporary design to serve a tech-oriented consumer base. The company's flagship Lucyd product line integrates audio capabilities and seamless connectivity, offering practical functionality while maintaining fashionable appeal. With an unwavering commitment to innovation and user experience enhancement, LUCY is poised to capitalize on the expanding demand for multifunctional wearables, positioning itself for substantial growth in the dynamic eyewear industry.